HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N- (6,6- dimethyl- 5- ((1- methylpiperidin- 4- yl)carbonyl)- 1,4,5,6- tetrahydropyrrolo(3,4- c)pyrazol- 3- yl)- 3- methylbutanamide

structure in first source
Also Known As:
PHA 793887; PHA-793887; PHA793887
Networked: 7 relevant articles (2 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Soria, Jean-Charles: 3 articles (03/2011 - 05/2010)
2. Kroemer, Guido: 2 articles (03/2011 - 01/2011)
3. Scaburri, Angela: 2 articles (03/2011 - 05/2010)
4. Ciomei, Marina: 2 articles (05/2010 - 04/2010)
5. Pesenti, Enrico: 2 articles (05/2010 - 04/2010)
6. Fu, Zhaoyu: 1 article (01/2021)
7. Ge, Junliang: 1 article (01/2021)
8. Guo, Zhen: 1 article (01/2021)
9. Liu, Daqun: 1 article (01/2021)
10. Liu, Jingyi: 1 article (01/2021)

Related Diseases

1. Osteosarcoma (Osteogenic Sarcoma)
2. Leukemia
3. Neoplasms (Cancer)
4. Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
5. Hematologic Neoplasms (Hematological Malignancy)

Related Drugs and Biologics

1. Cyclin-Dependent Kinases (cdk Proteins)
2. Toll-Like Receptors (Toll-Like Receptor)
3. Cytokines
4. Interleukin-6 (Interleukin 6)
5. Albendazole (Albenza)
6. Biomarkers (Surrogate Marker)
7. Mycophenolic Acid (Cellcept)
8. Interferons
9. Immunosorbents
10. Fenbendazole